Evidence map›Paper›PMID 19204093›Full record

ArticleInfection and immunity2009

Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum.

Alexander G Maier, Jake Baum, Brian Smith, David J Conway, Alan F Cowman

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Cellular and Molecular Interaction Between Erythrocytes andFrontiers in cellular and infection microbiology · 2022
    Review
  5. Review
  6. Article
  7. Low-Complexity Repetitive Epitopes ofFrontiers in immunology · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Alexander G MaierThe Walter and Eliza Hall Institute of Medical Research, Melbourne 3050, Australia.
Jake Baum
Brian Smith
David J Conway
Alan F Cowman
Walter and Eliza Hall Institute of Medical Research · AULondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MC_U190081987Wellcome Trust
6 · The paper itself

Abstract

Invasion of human erythrocytes by the malaria parasite Plasmodium falciparum utilizes multiple ligand-receptor interactions involving erythrocyte receptors and parasite erythrocyte binding proteins of the Duffy binding-like family. Erythrocyte binding antigen 175 (EBA-175) binds to glycophorin A, the most abundant protein on the human erythrocyte surface and EBA-140 (also known as BAEBL) binds to glycophorin C, while the receptor for EBA-181 (also known as JESEBL) remains unknown. EBA binding is mediated via region II, a highly structured extracellular domain that shows a degree of sequence variability between different laboratory strains/isolates. Here, we determined the influence of region II polymorphisms on host cell receptor binding and overall function during invasion of EBA-140, EBA-175, and EBA-181. Polymorphisms in the binding domains of EBA-140 and EBA-181 have been suggested previously to alter their respective receptor specificities. In our hands, these polymorphisms affected the levels of EBA-140 and EBA-181 binding to receptors but, critically, not the receptor specificities of these proteins. The degree of EBA-140 binding to glycophorin C correlates with the level of function for this ligand-receptor interaction in merozoite invasion. In contrast, EBA-175, which is highly polymorphic in region II, shows no variability in its ability to bind to its receptor, glycophorin A. Combined, these data highlight the importance of sequence variability in EBAs as driven by immune selection but not by receptor specificity.

Indexed as

Polymorphism, GeneticAnimalsAntigens, ProtozoanBinding SitesCarrier ProteinsErythrocytesGlycophorinsHumansLigandsMembrane GlycoproteinsMembrane ProteinsMiceMolecular Sequence DataPlasmodium falciparumProtein BindingProtozoan ProteinsAntigens, ProtozoanCarrier ProteinsEBA140 protein, Plasmodium falciparumEBA-181 protein, Plasmodium falciparumerythrocyte-binding antigen 175, PlasmodiumGlycophorinsLigandsMembrane GlycoproteinsMembrane ProteinsProtozoan ProteinsReceptors, ImmunologicSialic Acid Binding Ig-like Lectin 1SIGLEC1 protein, humanSiglec1 protein, mouse

Identifiers

PMID19204093
PMCPMC2663147
OpenAlexW2103845816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.